Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of rasagiline 1 mg as a first add-on treatment to dopamine agonist
therapy in early Parkinson Disease (PD) patients, , not optimally controlled on dopamine
agonists as compared to placebo.